• Mon news: Novartis Kisqali breast cancer trial. ESMO news: Bayer, Bristol Myers, Regeneron and more. Biosecure Act fallout. Boston Scientific/Silk Road merger. See more on our front page

whats really wrong with oncology development

Anonymous

Guest
gphs with no development experience
too many fmgs who don'ts speak english
too many foreign leaders like riva who hired his pets from last gig
riva is a musolini
herve is no david